Search
for
Sort by
Research 30 of 1000+
- Chemotherapy-Induced Alopecia
- Present Chemotherapy Induced Alopecia and Research in Future
- Targeting integrin pathways: mechanisms and advances in therapy
- Antibody Drug Conjugates
- 8. Pathology
- Lupus erythematosus: systemic and cutaneous manifestations
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- Immunosuppressive therapy in autoimmune disease — A review
- Side effects of methotrexate therapy in patients with rheumatoid arthritis
- Cutaneous Toxicities From Transplantation-Related Medications
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Getting to the root of hair loss in alopecia
- Therapeutic Application of Microsponges-based Drug Delivery Systems
- Microneedle Transdermal Drug Delivery Systems for Allergen-Specific Immunotherapy, Skin Disease Treatment, and Vaccine Development
- Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Hypersensitivity Diseases
- NANOPARTICLE-EMBEDDED MICRONEEDLES FOR ENHANCED TRANSDERMAL DELIVERY: ADVANCES AND APPLICATIONS
- Microneedles as a perspective for transdermal therapeutic systems
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Drug-induced acne
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Protective effect of Korean Red Ginseng against chemotherapeutic drug-induced premature catagen development assessed with human hair follicle organ culture model
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Cutaneous drug reactions
- Clinical Patterns of Cutaneous and Mucosal Lesions in Patients with Systemic Lupus Erythematosus